PFG Investments »

Xilio Therapeutics shares owned by PFG Investments

Quarter-by-quarter ownership of Xilio Therapeutics (XLO) shares owned by PFG Investments from 13F filings

Historical chart of PFG Investments investment in Xilio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Xilio Therapeutics held by PFG Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xilio Therapeutics by PFG Investments

Quarter filed Position value Share count Share price at filing
2024-03-31 $32k 30k 1.08

More positions owned by PFG Investments

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Tesla Motors (TSLA)
Meta Platforms Cl A (META)
Vanguard Bd Index Fds Intermed Term (BIV)
Pimco Dynamic Income SHS (PDI)
Johnson & Johnson (JNJ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Exxon Mobil Corporation (XOM)
JPMorgan Chase & Co. (JPM)
Ishares Tr Rus 1000 Grw Etf (IWF)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for PFG Investments

Top funds holding Xilio Therapeutics

Bain Capital Life Sciences Investors
FMR
RiverVest Venture Management
Rock Springs Capital Management
Atlas Venture Life Science Advisors
Vanguard Group
Balyasny Asset Management
Morgan Stanley
Fil
Geode Capital Management
Bridgeway Capital Management
Millennium Management
BlackRock
SevenBridge Financial
PFG Investments

View all funds holding Xilio Therapeutics